Search Orphan Drug Designations and Approvals
-
Generic Name: | blarcamesine |
---|---|
Date Designated: | 11/03/2022 |
Orphan Designation: | Treatment of Fragile X syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Anavex Life Sciences Corp. 630 5th Avenue, 20th Floor New York, New York 10111 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-